Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase III, Multicenter, Open-label, Randomized Trial of Tarceva® vs Chemotherapy in Patients With Advanced NSCLC With Mutations in the TK Domain of the EGFR

NCT00446225 is registered in ClinicalTrials.gov with Spanish Lung Cancer Group as lead sponsor.

NCT NCT00446225
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00446225 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase III, Multicenter, Open-label, Randomized Trial of Tarceva® vs Chemotherapy in Patients With Advanced NSCLC With Mutations in the TK Domain of the EGFR
Lead sponsor
Spanish Lung Cancer Group
Phase
Phase 3
Overall status
Completed
Start date
February 15, 2007
Completion date
December 31, 2012
Enrollment
174 (actual)
Sites
76

Conditions

As the registry lists them; a condition with its own page is linked.

non-small cell lung cancer